Using a specialized lab technique, scientists identified early cellular changes that may help drive lung scarring in ...

Columnist Sam Kirton talks to Scott Staszak, president and CEO of the Pulmonary Fibrosis Foundation, about the need for better research.

Pulmonary fibrosis (PF) is characterized by scarring, or fibrosis, in the lungs. Scar tissue development can interfere with the lungs’ ability to deliver oxygen to the bloodstream, as well as with ...

Tyvaso significantly improved a measure of lung function for IPF patients in a Phase 3 trial, which top-line data showed met ...

My recent pulmonary function test (PFT) results indicated a decline in all the areas it measured. That’s not unusual for me. In the spring, my PFT numbers had declined, as well, leading to a diagnosis ...

IPF, like any chronic, progressive, and incurable disease, causes many to ponder their legacy sooner than they anticipated. I recall that at the time of my diagnosis, I was told to “get my affairs in ...

Treatment with GRI Bio‘s investigational oral therapy GRI-0621 appears to reduce markers of fibrosis, or scarring, in people with idiopathic pulmonary fibrosis (IPF), according to an interim analysis ...

Fast shallow breathing (tachypnea) is one of several breathing difficulties experienced by pulmonary fibrosis (PF) patients. Breathing problems are common in PF because the disease causes progressive ...

It’s been hotter than usual here in the mid-Atlantic. Temperatures in the upper 90s, flirting with 100 F, plus high humidity made it feel like 107 to 115 F. If I had to sum it up in a single word, I’d ...

Being diagnosed in January 2017 with idiopathic pulmonary fibrosis (IPF) and learning that the disease is chronic, progressive, and incurable was a lot for one day. Of course, I wanted a cure or ...